Qualigen Therapeutics, Inc. (AIXC)
NASDAQ: AIXC · Real-Time Price · USD
2.880
-0.330 (-10.28%)
At close: Nov 19, 2025, 4:00 PM EST
2.900
+0.020 (0.69%)
After-hours: Nov 19, 2025, 4:37 PM EST
Qualigen Therapeutics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
4
Market Cap
4.88M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | 5.65M | 1.35M | 31.29% |
| Dec 31, 2020 | 4.31M | -1.25M | -22.52% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Amazon.com | 691.33B |
| Apple | 416.16B |
| Alphabet | 385.48B |
| Berkshire Hathaway | 372.13B |
| Microsoft | 293.81B |
| Meta Platforms | 189.46B |
| NVIDIA | 165.22B |
| Taiwan Semiconductor Manufacturing Company | 119.13B |